American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (986)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (940)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1255)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (311)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (62)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5172)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation sequencing of matched normal blood identifies clonal hematopoiesis in a significant subset of solid tumor patients without hematologic malignancies
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Middha, S.; Cheng, D.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Response to hypomethylating agent therapy in acute myeloid leukemia based upon mutations in the DNA methylation pathway
    Meeting Abstract

    Coombs, C. C.; Devlin, S.; Dixit, S.; Mohanty, A.; Knapp, K. M.; Arcila, M.; Klimek, V. M.; Tallman, M. S.; Levine, R. L.; Rampal, R. K.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Multi-center clinical trial of CAR T cells in pediatric/young adult patients with relapsed B-cell ALL
    Meeting Abstract

    Curran, K. J.; Riviere, I.; Silverman, L. B.; Kobos, R.; Shukla, N.; Steinherz, P. G.; Boulad, F.; Prockop, S.; Scaradavou, A.; Margossian, S. P.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Safety and efficacy of ferumoxytol for the treatment of iron deficiency anemia in a community based hematology clinic
    Meeting Abstract

    DeBolt, E.; Wagoner, J. A.; Tharnish, M.; Gonen, M.; Gauchan, D.; Rainaekers, R. C.; Clark, D.; Norvell, M.; Copur, M.
    Blood (2015)

    Fulltext@MSK | Save
  • Low dose unfractionated heparin (UFH) prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome (SOS) in adult allogeneic stem cell transplant (HSCT) recipients
    Meeting Abstract

    Bhatt, V.; Palazzo, M.; Kilroy, K.; Hilden, P.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H. R.; Chung, D. J.; Dahi, P. B.; Hsu, K. C.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • The peptidic CXCR4 antagonist, BL-8040, significantly reduces bone marrow immature leukemia progenitors by inducing differentiation, apoptosis and mobilization: Results of the dose escalation clinical trial in acute myeloid leukemia
    Meeting Abstract

    Borthakur, G.; Ofran, Y.; Nagler, A.; Rowe, J. M.; Foran, J. M.; Uy, G. L.; DiPersio, J. F.; Altman, J. K.; Frankfurt, O.; Tallman, M. S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • The combination of ATRA and dasatinib for differentiation therapy in acute myeloid leukemias with IDH mutations
    Meeting Abstract

    Boutzen, H.; Saland, E.; Cathebras, M.; Larrue, C.; Farge, T.; Serhan, N.; De Toni, F.; David, M.; Gales, L.; Castelli, F.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Risk factors and a prognostic score for progression free survival after treatment with autologous stem cell transplantation (ASCT) in patients with relapsed or refractory Hodgkin lymphoma (rrHL)
    Meeting Abstract

    BroĢˆckelmann, P. J.; Muller, H.; Casasnovas, O.; Hutchings, M.; von Tresckow, B.; Borchmann, P.; Moskowitz, C.; Engert, A.
    Blood (2015)

    Fulltext@MSK | Save
  • Patterns of lymphocytosis in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) treated with idelalisib
    Meeting Abstract

    Brown, J. R.; Cheson, B. D.; Furman, R. R.; Ghia, P.; Hallek, M.; Hillmen, P.; O'Brien, S. M.; Sharman, J. P.; Dubowy, R. L.; Velasco, B.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Differences in patients with progressive versus non-progressive AML, CLL, or NHL: Implications for proposed bundled payment strategies
    Meeting Abstract

    Byfield, S. D.; Engel-Nitz, N.; Bancroft, T.; Anderson, A. J.; Reyes, C.; Ravelo, A.; Ogale, S.; Chen, M.; Matasar, M. J.
    Blood (2015)

    Fulltext@MSK | Save